When was Transcarent founded?

Transcarent was founded in 2018 and became a unicorn in 2022, reaching the milestone in 4 years. It raised its 1st funding round 2 years after its incorporation.

Where is Transcarent located?

Transcarent is headquartered in San Francisco, United States. It is registered at San Francisco (United States).

Who is the current CEO of Transcarent?

Glen Tullman of Transcarent. They have also founded 1 company and are angel investors in 5 startups, including Livongo.

How many employees does Transcarent have?

As of Aug 31, 2026, the latest employee count at Transcarent is 953.

Is Transcarent a funded company?

Transcarent is a funded company, having raised a total of $424M across 4 funding rounds to date. The company's 1st funding round was a $40M Series A round, raised on Oct 22, 2020.

How much is Transcarent worth?

The latest valuation of Transcarent is $4B as of Jul 17, 2025.

When was the latest funding round of Transcarent?

Transcarent's latest funding was a $126M Series D round on May 02, 2024, with participation from 11 investors. Its primary sector is HRTech. In United States, the HRTech sector has seen $1.61B in funding in 2026 to date.

Is Transcarent a HRTech company?

The primary sectors of Transcarent are HRTech and Employee Health IT.

Where does Transcarent rank among its competitors?

Transcarent ranks 16th amongst 855 active competitors, of which 205 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Ekincare, which secured $1.01M in Jan, 2026.

Who are the top competitors of Transcarent?

Transcarent's top competitors include Hinge Health, Ekincare and Sharecare. Among them, Ekincare secured the most recent funding round in January, 2026.

Transcarent - 2026 Company Profile, Team, Funding & Competitors

Transcarent is a series D company based in San Francisco (United States), founded in 2018 by Glen Tullman and Michael Cline. It operates as a Provider of employee health benefits solutions. Transcarent has raised $424M in funding from investors like General Catalyst, 7wire Ventures and Kinnevik, with a current valuation of $4B. The company has 855 active competitors, including 205 funded and 117 that have exited. Its top competitors include companies like Hinge Health, Ekincare and Sharecare.

Sectors and market segments that Transcarent operate in

Transcarent serves in the HealthTech market segments.The primary business model of Transcarent is:

HealthTech > Employee Health IT > ***** **** > ***** ******

Company Details

Provider of employee health benefits solutions. Platform offers AI-powered tool that guides users through their healthcare journey, helping them navigate benefits, clinical guidance, and care delivery. The platform connects users with both virtual and in-person care options and support for various health needs, including mental health, cancer care, and weight health.

Website: transcarent.com
Social
Email ID: *****@transcarent.ai
Registered Address: San Francisco (United States)

Key Metrics

Founded Year

2018

Location

San Francisco, United States

Stage

Series D

Total Funding

$424M in 4 rounds

Latest Funding Round

Series D, May 02, 2024, $126M

Post Money Valuation

$4B as on Jul 17, 2025

Investors

General Catalyst & 19 more

Ranked

16^th among 855 active competitors

Employee Count

953 as on Aug 31, 2026

Investment & Acquisitions

Accolade & 2 more

Similar Companies

Hinge Health & 1046 more

View Transcarent's full profile

Transcarent is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Transcarent, Inc. CIN: 84-3296541 , United States, Active	Dec 31, 2017	-	348 (As on Dec 31, 2024)	-

Transcarent has raised a total funding of $424M over 4 rounds. Its first funding round was on Oct 22, 2020. Its latest funding round was a Series D round on May 02, 2024 for $126M. 11 investors participated in its latest round. Transcarent has 20 institutional investors.

Here is the list of recent funding rounds of Transcarent:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 02, 2024	$126M	Series D	$2.2B	-	General Catalyst, 7wire Ventures	Geodesic Capital, Memorial Hermann, Threshold, Kinnevik, Ally Bridge Group, Human Capital, Merck Global Health Innovation Fund, Alta Partners, Leaps by Bayer
Jan 11, 2022	$200M	Series C	$1.62B	-	Kinnevik, Human Capital	Northwell, Intermountain Healthcare, Rush University Medical Center, Village of New Hyde Park, General Catalyst, 7wire Ventures, Alta Partners, GreatPoint Ventures, Merck Global Health Innovation Fund, Ally Bridge Group, Threshold, Jove Equity Partners
Jun 10, 2021	$58M	Series B	-	-	General Catalyst, 7wire Ventures	Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, Threshold, Alta Partners, Jove Equity Partners

Access funding benchmarks and valuations. Sign up today!

View details of Transcarent's funding rounds and investors

The founders of Transcarent are Glen Tullman and Michael Cline. Glen Tullman is the CEO of Transcarent.

Here are the details of Transcarent's key team members:

Glen Tullman: Founder & CEO of Transcarent and founder of 1 other company. They are also an angel investor in 5 startups.
Michael Cline: Founder, Chairman of Transcarent and founder of 7 other companies, including J Michael Cline - Founder Chairman, DXC Technology and Everspring. They are also an angel investor in 1 startup.

Transcarent's Board of Directors

Transcarent's board has 7 active members. Hemant Taneja, Lee Shapiro, Glen Tullman, Holly Maloney, Erica Davila, Stephanie Peng and Ken Frazier are independent board members.

Here is the list of Transcarent's board of directors:

Name	Type	Representing	Status	Duration
Hemant Taneja	Independent board member	-	Current	1y 5m
Lee Shapiro	Independent board member	-	Current	1y 5m
Glen Tullman	Independent board member	-	Current	1y 5m
Holly Maloney	Independent board member	-	Current	1y 5m
Erica Davila	Independent board member	-	Current	1y 5m
Stephanie Peng	Independent board member	-	Current	1y 5m
Ken Frazier	Independent board member	-	Current	1y 5m

View details of Transcarent's Founder profiles and Board Members

Transcarent's employee count trend

Transcarent has 953 employees as of Aug 26. Here is Transcarent's employee count trend over the years:

Uncover Transcarent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Transcarent include Hinge Health, Ekincare and Sharecare. Here is the list of Top 10 competitors of Transcarent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Hinge Health 2015, San Francisco (United States), Public	Provider of virtual physical therapy and digital pain care solutions	$854M	Tiger Global Management, Coatue & 14 others	84/100
2nd	Ekincare 2015, Hyderabad (India), Series B	Provider of employee health benefits platform offering health and wellness programs	$28M	Ventureast, HealthQuad & 43 others	79/100
3rd	Sharecare 2010, United States, Acquired	Provider of health and wellness social network for employees	$64M	Trinity Health, Summit Partners & 25 others	79/100
4th	Castlight 2008, San Francisco (United States), Acquired	Cloud-based healthcare information on providers and pricing for enterprises	$181M	T. Rowe Price, Redmile Group & 10 others	76/100
5th	Optum 2008, Chennai (India), Acquired	Provider of integrated healthcare services encompassing care delivery, financial solutions, and pharmacy services	-	Insight Partners, Riata Capital	75/100
6th	Sword Health 2015, New York (United States), Series E	Provider of AI-powered digital physical therapy and pelvic health solutions	$450M	Khosla Ventures, General Catalyst & 39 others	75/100
7th	Wellhub 2012, New York City (United States), Series F	Cloud based corporate wellness program for employee health, productivity, and retention	$85M	EQT, General Atlantic & 22 others	75/100
8th	HealthEquity 2002, Draper (United States), Public	Employee benefits management platform for individuals and businesses	$15.3M	Berkley Capital, Napier Park Global Capital ... & 4 others	74/100
9th	Accolade 2007, Plymouth Meeting (United States), Acquired	Cloud-based platform for employee health benefits	$228M	McKesson, Andreessen Horowitz & 17 others	74/100
10th	Healthee 2021, New York City (United States), Series B	AI-powered health benefits application for healthcare services	$84M	Glilot Capital Partners, Fin Capital & 8 others	73/100
16th	Transcarent 2018, San Francisco (United States), Series D	Provider of employee health benefits solutions	$424M	Threshold, Kinnevik & 18 others	71/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Transcarent's competitors? Click here to see the top ones

Transcarent has acquired 3 companies including Accolade, 98point6 and BridgeHealth. Transcarent has not made any investments as of now.

Here is the list of its acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
-	Acquisition	BridgeHealth	2007	Denver (United States)
Jan 08, 2025	Acquisition	Accolade	2007	Plymouth Meeting (United States)
Mar 06, 2023	Acquisition	98point6	2015	Seattle (United States)